Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 19/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 19/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 9/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21606459 | 0.89 | PIK3CD (0.65) | PIK3CDSLC6A2SLC6A4SLC6A3KCNH2 | |
| Hydrochloric Acid SCHEMBL21597911 | 0.88 | PIK3CD (0.63) | PIK3CDSLC6A2SLC6A4SLC6A3KCNH2 | |
| Trifluoroacetic Acid SCHEMBL18428991 | 0.84 | SLC6A4 (0.42) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL27707181 | 0.81 | SLC6A2 (0.50) | PIK3CDSLC6A2SLC6A4SLC6A3KCNH2 | |
| Trifluoroacetic Acid SCHEMBL22797910 | 0.81 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| Trifluoroacetic Acid SCHEMBL22797954 | 0.81 | SLC6A4 (0.40) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| Trifluoroacetic Acid SCHEMBL22797934 | 0.81 | SLC6A4 (0.44) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| Trifluoroacetic Acid SCHEMBL22449323 | 0.81 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| Trifluoroacetic Acid SCHEMBL27205163 | 0.78 | SLC6A2 (0.38) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| Hydrochloric Acid SCHEMBL22797930 | 0.77 | PIK3CD (0.45) | PIK3CDSLC6A2SLC6A4SLC6A3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3822262-B1 | MUSCARINIC AGONISTS | HEPTARES THERAPEUTICS LTD (GB) | 2024-03-27 | — | — | EP | disclosed |
| EP-3822262-A1 | MUSCARINIC AGONISTS | Heptares Therapeutics Limited (GB) | 2021-05-19 | — | — | EP | disclosed |
| EP-3331869-B1 | MUSCARINIC AGONISTS | HEPTARES THERAPEUTICS LTD (GB) | 2020-12-23 | — | — | EP | disclosed |